Includes bibliographical references and index.
|Statement||edited by Sven Frøkjær and Lars Hovgaard.|
|Series||The Taylor & Francis series in pharmaceutical sciences|
|Contributions||Frøkjær, Sven, 1947-, Hovgaard, Lars, 1962-|
|LC Classifications||RS431.P75 P47 1999|
|The Physical Object|
|Pagination||xviii, 238 p. :|
|Number of Pages||238|
|LC Control Number||99035816|
The rapid advances in recombinant DNA technology and the increasing availability of peptides and proteins with therapeutic potential are a challenge for pharmaceutical scientists who have to formulate these compounds as drug products. Pharmaceutical Formulation Development of Peptides and Proteins, Second Edition discusses the development Cited by: Pharmaceutical Formulation Development of Peptides and Proteins, Second Edition Unknown Binding See all formats and editions Hide other formats and editions. Price New from Used from . In order to develop products with optimal characters, it is important to give scientists interdisciplinary knowledge and a thorough understanding of the complex nature of pharmaceutical formulation of peptides and comprehensive volume brings the different aspects of peptide and protein formulation into focus, beginning with the fundamentals of the production of peptides and proteins, ranging from peptide synthesis and recombinant DNA technology to protein purification. Pharmaceutical Formulation Development of Peptides and Proteins, Second Edition discusses the development of therapeutic peptides and proteins, from the production of active compounds via basic pre-formulation and formulation to the registration of the final product. Providing integrated solutions, this book discusses:The synthesis of peptides and the biotechnolog.
Pharmaceutical formulation of peptides and proteins has become an important part of modern drug development. Many new drugs are based on peptide or protein recombinant technology going hand in hand with more traditional pharmaceutical formulation. Pharmaceutical Formulation Development of Peptides and Proteins. Proteins/peptides are generally much more sensitive to process- or storage-induced degradations than small synthetic molecules. Therefore, significant efforts are needed to formulate these protein/peptide drug candidates into viable commercial chapter reviews the degradation processes in proteins/peptides, describes factors affecting protein/peptide . Pharmaceutical Formulation Development of Peptides and Proteins Hardcover – 16 January by Lars Hovgaard (Editor), Sven Frokjaer (Editor), Marco van de Weert (Editor) out of 5 stars 2 /5(2).
Pharmaceutical Powder Compaction Technology, Second Edition, edited by Metin Celik Handbook of Pharmaceutical Granulation Technology, Dilip M. Parikh Pharmaceutical Preformulation and Formulation. Numerous strategies suggested the use of formulation vehicles, such as microemulsions, liposomes, nanoparticles, and microspheres to protect the protein formulation against the harsh environment of the GIT (acidic medium and enzymes) so as to achieve successful delivery of proteins and peptides . Pharmaceutical Formulation Development of Peptides and Proteins: : Hovgaard, Lars, Frokjaer, Sven, van de Weert, Marco: Libros en idiomas extranjeros/5(2). Protein and Peptide drug delivery system are the Novel drug Delivery System. Proteins and peptides are the most abundant components of biological cells. They exist functioning such as enzymes.